Abstract
ctDNA may have limited ability to monitor treatment response in patients with heavily pre-treated malignancies
Cite
CITATION STYLE
APA
Hu, Y., Narayan, A., Xu, Y., Wolfe, J., Vu, D., Trinh, T., … Patel, A. A. (2024). Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO Precision Oncology, (8). https://doi.org/10.1200/po.23.00289
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free